Birchview Capital, LP’s Acadia Pharmaceuticals Inc Position
Does Birchview Capital, LP own Acadia Pharmaceuticals Inc (ACAD)? Yes — 171.0K shares worth $4M (+2.17% of its 13F portfolio) as of Q1 2026.
Position Value
$4M
Q1 2026
Shares
171.0K
% of Portfolio
+2.17%
Quarters Held
28
currently held
Position History ACAD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 171.0K | $4M | +2.17% |
| Q4 2025 | 171.0K | $5M | +2.67% |
| Q3 2025 | 171.0K | $4M | +2.76% |
| Q2 2025 | 187.8K | $4M | +4.02% |
| Q1 2025 | 263.4K | $4M | +3.80% |
| Q4 2024 | 338.4K | $6M | +5.06% |
| Q3 2024 | 400.4K | $6M | +5.34% |
| Q2 2024 | 250.4K | $4M | +3.77% |
| Q1 2024 | 250.4K | $5M | +3.78% |
| Q4 2023 | 240.4K | $8M | +5.90% |
| Q3 2023 | 240.4K | $5M | +4.26% |
| Q2 2023 | 249.4K | $6M | +4.48% |
| Q1 2023 | 249.4K | $4,694 | +3.68% |
| Q4 2022 | 249.4K | $3,970 | +2.80% |
| Q3 2022 | 249.4K | $4M | +2.87% |
| Q2 2022 | 249.4K | $4M | +2.56% |
| Q1 2022 | 199.4K | $5M | +3.48% |
| Q4 2021 | 199.4K | $5M | +3.00% |
| Q3 2021 | 199.4K | $3M | +2.25% |
| Q2 2021 | 199.4K | $5M | +2.91% |
| Q1 2021 | 177.0K | $5M | +2.71% |
| Q4 2020 | 102.0K | $5M | +3.14% |
| Q3 2020 | 102.0K | $4M | +2.81% |
| Q2 2020 | 93.0K | $5M | +2.72% |
| Q1 2020 | 92.0K | $4M | +3.45% |
| Q4 2019 | 14.0K | $599,000 | +0.44% |
| Q3 2019 | 14.0K | $504,000 | +0.34% |
| Q2 2019 | 10.0K | $267,000 | +0.16% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of ACAD.